{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:43:49Z","timestamp":1793839429177,"version":"4.6.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.phymed.2024.156224","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T13:32:09Z","timestamp":1732368729000},"page":"156224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Icariin promoted ferroptosis by activating mitochondrial dysfunction to inhibit colorectal cancer and synergistically enhanced the efficacy of PD-1 inhibitors"],"prefix":"10.1016","volume":"136","author":[{"given":"Wang","family":"Haoyue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Kexiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan Wei","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Jiamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Luyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Junkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng","family":"Wanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.156224_bib0001","doi-asserted-by":"crossref","first-page":"k793","DOI":"10.1136\/bmj.k793","article-title":"Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis","volume":"360","author":"Baxi","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2024.156224_bib0002","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.celrep.2014.08.056","article-title":"Fatty acid uptake and lipid storage induced by HIF-1\u03b1 contribute to cell growth and survival after hypoxia-reoxygenation","volume":"9","author":"Bensaad","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.phymed.2024.156224_bib0003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/15569527.2022.2034842","article-title":"Adverse cutaneous toxicities by PD-1\/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance","volume":"41","author":"Bhardwaj","year":"2022","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.phymed.2024.156224_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113180","article-title":"Anti-inflammatory and immunoregulatory effects of icariin and icaritin","volume":"151","author":"Bi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2024.156224_bib0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.phymed.2024.156224_bib0006","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/2326-6066.CIR-21-0515","article-title":"Reversing T-cell exhaustion in cancer: lessons learned from PD-1\/PD-L1 immune checkpoint blockade","volume":"10","author":"Budimir","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.phymed.2024.156224_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-024-00934-z","article-title":"Mechanisms of metastatic colorectal cancer","author":"Ca\u00f1ellas-Socias","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2024.156224_bib0008","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","article-title":"Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance","volume":"27","author":"Cao","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.phymed.2024.156224_bib0009","article-title":"Icariin inhibits prostate cancer bone metastasis and destruction via suppressing TAM\/CCL5-mediated osteoclastogenesis","volume":"120","author":"Chen","year":"2023","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.phymed.2024.156224_bib0010","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3390\/ijms24021607","article-title":"Prospects for anti-tumor mechanism and potential clinical application based on glutathione peroxidase 4 mediated ferroptosis","volume":"24","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.156224_bib0011","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.phymed.2024.156224_bib0012","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/2326-6066.CIR-20-0384","article-title":"Pharmacologic screening identifies metabolic vulnerabilities of CD8+ T cells","volume":"9","author":"Drijvers","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.phymed.2024.156224_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phymed.2024.156224_bib0014","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.7150\/ijbs.64077","article-title":"Immunotherapy in colorectal cancer: current achievements and future perspective","volume":"17","author":"Fan","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2024.156224_bib0015","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202105043","article-title":"Mitochondrial regulation of ferroptosis","volume":"220","author":"Gan","year":"2021","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phymed.2024.156224_bib0016","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2147\/DDDT.S398887","article-title":"Icariin induces triple-negative breast cancer cell apoptosis and suppresses invasion by inhibiting the JNK\/c-Jun signaling pathway","volume":"17","author":"Gao","year":"2023","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.phymed.2024.156224_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110170","article-title":"Colon cancer and colorectal cancer: prevention and treatment by potential natural products","volume":"368","author":"Islam","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phymed.2024.156224_bib0018","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phymed.2024.156224_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101660","article-title":"Immune checkpoint inhibitor-related thyroid dysfunction","volume":"36","author":"Iwama","year":"2022","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phymed.2024.156224_bib0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phymed.2024.156224_bib0021","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12967-018-1611-7","article-title":"Unleashing endogenous TNF-alpha as a cancer immunotherapeutic","volume":"16","author":"Josephs","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phymed.2024.156224_bib0022","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/annonc\/mdx286","article-title":"Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review","volume":"28","author":"Khoja","year":"2017","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.phymed.2024.156224_bib0023","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2024.156224_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216119","article-title":"Targeting GPX4 in human cancer: implications of ferroptosis induction for tackling cancer resilience","volume":"559","author":"Lee","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.156224_bib0025","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.7150\/ijbs.83348","article-title":"The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phymed.2024.156224_bib0026","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.canlet.2021.09.034","article-title":"Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China, Europe, and northern America","volume":"522","author":"Li","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.156224_bib0027","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41568-022-00537-3","article-title":"STAT proteins in cancer: orchestration of metabolism","volume":"23","author":"Li","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2024.156224_bib0028","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/ijms24021436","article-title":"\u03b1-Synuclein induces neuroinflammation injury through the IL6ST-AS\/STAT3\/HIF-1\u03b1 axis","volume":"24","author":"Lin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.156224_bib0029","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1007\/s00262-023-03520-5","article-title":"PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies","volume":"72","author":"Lin","year":"2023","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"10.1016\/j.phymed.2024.156224_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10495-023-01891-9","article-title":"Advancing the frontiers of colorectal cancer treatment: harnessing ferroptosis regulation","volume":"29","author":"Liu","year":"2024","journal-title":"Apoptosis Int. J. Program. Cell Death"},{"key":"10.1016\/j.phymed.2024.156224_bib0031","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","article-title":"The diversified role of mitochondria in ferroptosis in cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phymed.2024.156224_bib0032","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2024.156224_bib0033","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1002\/ctm2.422","article-title":"Single-cell analyses reveal suppressive tumor microenvironment of human colorectal cancer","volume":"11","author":"Mei","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.phymed.2024.156224_bib0034","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.156224_bib0035","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2024.156224_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.727306","article-title":"Calmodulin 2 Facilitates Angiogenesis and Metastasis of Gastric Cancer via STAT3\/HIF-1A\/VEGF-A Mediated Macrophage Polarization","volume":"11","author":"Mu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phymed.2024.156224_bib0037","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/annonc\/mdv383","article-title":"Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies","volume":"26","author":"Naidoo","year":"2015","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.phymed.2024.156224_bib0038","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","article-title":"Metastatic colorectal cancer: mechanisms and emerging therapeutics","volume":"44","author":"Shin","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phymed.2024.156224_bib0039","first-page":"233","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.phymed.2024.156224_bib0040","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1111\/cas.14648","article-title":"Icariin-induced inhibition of SIRT6\/NF-\u03baB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer","volume":"111","author":"Song","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phymed.2024.156224_bib0041","doi-asserted-by":"crossref","first-page":"e7151","DOI":"10.1590\/1414-431x20187151","article-title":"Icariin reduces human colon carcinoma cell growth and metastasis by enhancing p53 activities","volume":"51","author":"Tian","year":"2018","journal-title":"Braz. J. Med. Biol. Res. Rev. Bras. Pesqui. Medicas E Biol."},{"key":"10.1016\/j.phymed.2024.156224_bib0042","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2024.156224_bib0043","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/d41573-022-00030-4","article-title":"Challenges and opportunities in the PD1\/PDL1 inhibitor clinical trial landscape","volume":"21","author":"Upadhaya","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2024.156224_bib0044","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.13520","article-title":"Human FOXP3 and tumour microenvironment","volume":"168","author":"Wang","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.phymed.2024.156224_bib0045","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1142\/S0192415X20500780","article-title":"Positive role of Chinese herbal medicine in cancer immune regulation","volume":"48","author":"Wang","year":"2020","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phymed.2024.156224_bib0046","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2024.156224_bib0047","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-020-0144-8","article-title":"PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phymed.2024.156224_bib0048","article-title":"Emerging roles for HMGA2 in colorectal cancer","volume":"14","author":"Wang","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.phymed.2024.156224_bib0049","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7150\/thno.65411","article-title":"HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics."},{"key":"10.1016\/j.phymed.2024.156224_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216038","article-title":"Immune checkpoint inhibitor resistance in hepatocellular carcinoma","volume":"555","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2024.156224_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.phymed.2024.156224_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112945","article-title":"HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.phymed.2024.156224_bib0053","doi-asserted-by":"crossref","first-page":"e13644","DOI":"10.1111\/cpr.13644","article-title":"Targeting novel regulated cell death: ferroptosis, pyroptosis and necroptosis in anti-PD-1\/PD-L1 cancer immunotherapy","author":"Yu","year":"2024","journal-title":"Cell Prolif."},{"key":"10.1016\/j.phymed.2024.156224_bib0054","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.apsb.2021.07.016","article-title":"Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2024.156224_bib0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324008341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324008341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T14:25:54Z","timestamp":1736605554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324008341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":55,"alternative-id":["S0944711324008341"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.156224","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Icariin promoted ferroptosis by activating mitochondrial dysfunction to inhibit colorectal cancer and synergistically enhanced the efficacy of PD-1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.156224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156224"}}